Thus, as the SLC1A5 variant is the only currently known glutamine transporter in the mitochondrial inner membrane 16 , targeting the SLC1A5 variant could be an effective strategy for selectively inhibiting glutamine metabolism in cancer cells (Fig
Secondly, oxidative-inflammatory axis further disrupts autophagy, impairing clearance of damaged organelles and proteins, which perpetuates cellular dysfunction and fibrosis (Jun-Hao et al., 2022
A C K N O W L E D G E M E N T S The authors would like to thank A
Targeting inflammation to cut cardiovascular risk The main modifiable drivers of cardiovascular disease are high LDL cholesterol, hypertension, smoking, diabetes, obesity, atrial fibrillation, chronic inflammation, and lipoprotein(a)
WARNING If you are pregnant, nursing, or have a medical condition, consult your healthcare professional before use
While they may offer benefits, they come with more significant considerations: Source quality matters: Not all compounding pharmacies follow strict standards No established protocols: Dosing varies widely Limited human safety data: Most research is preclinical Potential for side effects: Including injection site reactions, immune responses, and unknown long-term effects Regulatory status: Most are not FDA-approved for any medical indication Safety Considerations and Final Thoughts Peptides are an exciting area of research, and we are optimistic about their potential role in plastic surgery recovery
